1. bookVolume 71 (2021): Issue 3 (September 2021)
Journal Details
License
Format
Journal
eISSN
1820-7448
First Published
25 Mar 2014
Publication timeframe
4 times per year
Languages
English
access type Open Access

Crosstalks Among Cancer Stem Cells and Histopathologic Features in Determining Prognosis in Canine Mammary Gland Carcinomas

Published Online: 27 Sep 2021
Volume & Issue: Volume 71 (2021) - Issue 3 (September 2021)
Page range: 303 - 317
Accepted: 23 Aug 2021
Journal Details
License
Format
Journal
eISSN
1820-7448
First Published
25 Mar 2014
Publication timeframe
4 times per year
Languages
English
Abstract

The purpose of the present work was the evaluation of the prognostic potential of histopathologic features, cancer stem cells (CSCs), and epthelial-mesenchymal transition (EMT) in relation to lymph node status and lymphovascular invasion (LVI) in canine mammary gland carcinomas (CMGCs). CSCs are proposed as the main cause of tumorigenesis, therapy failure, and recurrence which form a small fraction of tumor bulk. We evaluated presence of micropapillary growth pattern (MGP), infiltration into surrounding tissues (IST), and vasculogenic mimicry (VM) in H&E stained slides of 26 paraffin-embedded tumor samples. Lymph nodes of all cases were assessed. Additionally, they were examined immunohistochemically in terms of vimentin expression as an indicator of EMT which is a well-known mechanism for metastasis, and CD44, CD24, and ALDH1 for CSCs detection. Data analyses showed significant relationships between MGP and CSCs (P = 0.037), VM and CSCs (P = 0.013), lymph node status and CSCs (P = 0.0001), lymph node status and EMT (P = 0.003), IST and LVI (P = 0.05), VM and LVI (P = 0.01), VM and lymph node status (P = 0.007), and LVI and lymph node status (P = 0.04). Results indicated the prognostic value of MGP, VM, and CSCs with respect to confirmed prognostic markers, including LVI and lymph node involvement, in CMGCs.

Keywords

1. Nguyen F, Peña L, Ibisch C, Loussouarn D, Gama A, Rieder N, Belousov A, Campone M, Abadie J: Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors. Breast cancer research and treatment 2018, 167:635-648.10.1007/s10549-017-4548-2580749429086231 Search in Google Scholar

2. Rasotto R, Zappulli V, Castagnaro M, Goldschmidt MH: A retrospective study of those histopathologic parameters predictive of invasion of the lymphatic system by canine mammary carcinomas. Veterinary pathology 2012, 49:330-340.10.1177/030098581140925321670194 Search in Google Scholar

3. Gray M, Meehan J, Martínez-Pérez C, Kay C, Turnbull AK, Morrison LR, Pang LY, Argyle D: Naturally-occurring canine mammary tumors as a translational model for human breast cancer. Frontiers in oncology 2020,10.10.3389/fonc.2020.00617719876832411603 Search in Google Scholar

4. Marconato L, Facchinetti A, Zanardello C, Rossi E, Vidotto R, Capello K, Melchiotti E, Laganga P, Zamarchi R, Vascellari M: Detection and prognostic relevance of circulating and disseminated tumour cell in dogs with metastatic mammary carcinoma: a pilot study. Cancers 2019, 11:163.10.3390/cancers11020163640671630717110 Search in Google Scholar

5. Ayob AZ, Ramasamy TS: Cancer stem cells as key drivers of tumour progression. Journal of biomedical science 2018, 25:1-8.10.1186/s12929-018-0426-4583895429506506 Search in Google Scholar

6. Paul CD, Mistriotis P, Konstantopoulos K: Cancer cell motility: lessons from migration in confined spaces. Nature Reviews Cancer 2017, 17:131-140.10.1038/nrc.2016.123536449827909339 Search in Google Scholar

7. Ye F, Yu P, Li N, Yang A, Xie X, Tang H, Liu P: Prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in breast: A meta-analysis of PSM studies. The Breast 2020, 51:11-20.10.1016/j.breast.2020.01.041737557332172190 Search in Google Scholar

8. Lin H, Hong Y, Huang B, Liu X, Zheng J, Qiu S: Vimentin Overexpressions induced by cell hypoxia promote Vasculogenic mimicry by renal cell carcinoma cells. BioMed research international 2019, 2019.10.1155/2019/7259691667989531428643 Search in Google Scholar

9. Zhang JG, Zhou HM, Zhang X, Mu W, Hu JN, Liu GL, Li Q: Hypoxic induction of vasculogenic mimicry in hepatocellular carcinoma: role of HIF-1 α, RhoA/ROCK and Rac1/PAK signaling. BMC cancer 2020, 20:1-3.10.1186/s12885-019-6501-8695878931931758 Search in Google Scholar

10. Strouhalova K, Přechová M, Gandalovičová A, Brábek J, Gregor M, Rosel D: Vimentin intermediate filaments as potential target for cancer treatment. Cancers 2020, 12:184.10.3390/cancers12010184701723931940801 Search in Google Scholar

11. Te Boekhorst V, Friedl P: Plasticity of cancer cell invasion—Mechanisms and implications for therapy. Advances in cancer research 2016, 132:209-64.10.1016/bs.acr.2016.07.00527613134 Search in Google Scholar

12. Jahanban-Esfahlan R, Seidi K, Manjili MH, Jahanban-Esfahlan A, Javaheri T, Zare P: Tumor cell dormancy: threat or opportunity in the fight against cancer. Cancers 2019, 11:1207.10.3390/cancers11081207672180531430951 Search in Google Scholar

13. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.10.1016/j.cell.2008.03.027272803218485877 Search in Google Scholar

14. Strati A, Nikolaou M, Georgoulias V, Lianidou ES: Prognostic significance of TWIST1, CD24, CD44, and ALDH1 transcript quantification in EpCAM-positive circulating tumor cells from early stage breast cancer patients. Cells 2019, 8:652.10.3390/cells8070652667922231261917 Search in Google Scholar

15. Rybicka A, Król M; Identification and characterization of cancer stem cells in canine mammary tumors. Acta Veterinaria Scandinavica 2016, 58:1-7.10.1186/s13028-016-0268-6516871427993142 Search in Google Scholar

16. MaroufiNF, Amiri M, Dizaji BF, Vahedian V, Akbarzadeh M, Roshanravan N, Haiaty S, Nouri M, Rashidi MR: Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells. European Journal of Pharmacology 2020, 881:173282.10.1016/j.ejphar.2020.17328232580038 Search in Google Scholar

17. Meuten DJ. Tumors in domestic animals. 5th ed. Wiley Blackwell; 2016. pp. 723-765.10.1002/9781119181200 Search in Google Scholar

18. Clemente M, Perez-Alenza MD, Illera JC, Peña L: Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer. Veterinary Pathology 2010, 47:265-274.10.1177/030098580935316720106772 Search in Google Scholar

19. Hujanen R, Almahmoudi R, Karinen S, Nwaru BI, Salo T, Salem A: Vasculogenic mimicry: a promising prognosticator in head and neck squamous cell carcinoma and esophageal cancer? a systematic review and meta-analysis. Cells 2020, 9:507.10.3390/cells9020507707276532102317 Search in Google Scholar

20. Mahooti S, Porter K, Alpaugh ML, Ye Y, Xiao Y, Jones S, Tellez JD, Barsky SH: Breast carcinomatous tumoral emboli can result from encircling lymphovasculogenesis rather than lymphovascular invasion. Oncotarget 2010, 1:131.10.18632/oncotarget.117 Search in Google Scholar

21. Chen J, Chen S, Zhuo L, Zhu Y, Zheng H: Regulation of cancer stem cell properties, angiogenesis, and vasculogenic mimicry by miR-450a-5p/SOX2 axis in colorectal cancer. Cell death & disease 2020, 11:1-3.10.1038/s41419-020-2361-z706032032144236 Search in Google Scholar

22. Prado MC, Macedo SD, Guiraldelli GG, de Faria Lainetti P, Leis-Filho AF, Kobayashi PE, Laufer-Amorim R, Fonseca-Alves CE: Investigation of the prognostic significance of vasculogenic mimicry and its inhibition by sorafenib in canine mammary gland tumors. Frontiers in oncology 2019, 9:1445.10.3389/fonc.2019.01445693092931921690 Search in Google Scholar

23. Xu J, Zhang Y, Wang Y, Tao X, Cheng L, Wu S, Tao Y: Correlation of KAI1, CD133 and vasculogenic mimicry with the prediction of metastasis and prognosis in hepatocellular carcinoma. International journal of clinical and experimental pathology 2018, 11:3638. Search in Google Scholar

24. Andonegui-Elguera MA, Alfaro-Mora Y, Cáceres-Gutiérrez R, Caro-Sánchez CH, Herrera LA, Díaz-Chávez J: An Overview of Vasculogenic Mimicry in Breast Cancer. Frontiers in oncology 2020, 10.10.3389/fonc.2020.00220705688332175277 Search in Google Scholar

25. Lee SY, Jeong EK, Ju MK, Jeon HM, Kim MY, Kim CH, Park HG, Han SI, Kang HS: Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation. Molecular cancer 2017, 16:1-25.10.1186/s12943-016-0577-4528272428137309 Search in Google Scholar

26. Zhang X, Xing C, Guan W, Chen L, Guo K, Yu A, Xie K: Clinicopathological and prognostic significance of nestin expression in patients with breast cancer: a systematic review and meta-analysis. Cancer cell international 2020, 20:1-7.10.1186/s12935-020-01252-5722726432467665 Search in Google Scholar

27. Cao Z, Bao M, Miele L, Sarkar FH, Wang Z, Zhou Q: Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: a systemic review and meta-analysis. European journal of cancer 2013, 49:3914-3923.10.1016/j.ejca.2013.07.14823992642 Search in Google Scholar

28. Wu Q, Wang J, Liu Y, Gong X: Epithelial cell adhesion molecule and epithelial-mesenchymal transition are associated with vasculogenic mimicry, poor prognosis, and metastasis of triple negative breast cancer. International journal of clinical and experimental pathology 2019, 12:1678. Search in Google Scholar

29. Li S, Li Q: Cancer stem cells and tumor metastasis. International journal of oncology 2014, 44:1806-12.10.3892/ijo.2014.2362406353624691919 Search in Google Scholar

30. Ahmadi SA, Moinfar M, Moghaddam KG, Bahadori M: Practical application of angiogenesis and vasculogenic mimicry in prostatic adenocarcinoma. Archives of Iranian medicine 2010, 13:498-503. Search in Google Scholar

31. Zhao XL, Du J, Zhang SW, Liu YX, Wang X, Sun BC: A study on vasculogenic mimicry in hepatocellular carcinoma. Zhonghua gan zang bing za zhi= Zhonghua ganzangbing zazhi= Chinese journal of hepatology 2006, 14:41-44. Search in Google Scholar

32. Aleskandarany MA, Sonbul SN, Mukherjee A, Rakha EA: Molecular mechanisms underlying lymphovascular invasion in invasive breast cancer. Pathobiology 2015, 82:113-23.10.1159/00043358326330352 Search in Google Scholar

33. Lavenus SB, Tudor SM, Ullo MF, Vosatka KW, Logue JS: A flexible network of vimentin intermediate filaments promotes migration of amoeboid cancer cells through confined environments. Journal of Biological Chemistry 2020, 295:6700-6709.10.1074/jbc.RA119.011537721262232234762 Search in Google Scholar

34. Daubriac J, Han S, Grahovac J, Smith E, Hosein A, Buchanan M, Basik M, Boucher Y: The crosstalk between breast carcinoma-associated fibroblasts and cancer cells promotes RhoA-dependent invasion via IGF-1 and PAI-1. Oncotarget 2018, 9:10375.10.18632/oncotarget.23735582821329535813 Search in Google Scholar

35. Vorotnikov AV, Tyurin-Kuzmin PA: Chemotactic signaling in mesenchymal cells compared to amoeboid cells. Genes & diseases 2014, 1:162-73.10.1016/j.gendis.2014.09.006615006830258862 Search in Google Scholar

36. Yang YL, Liu BB, Zhang X, Fu L: Invasive micropapillary carcinoma of the breast: an update. Archives of pathology & laboratory medicine 2016, 140:799-805.10.5858/arpa.2016-0040-RA27472238 Search in Google Scholar

37. Lee JH, Kim JH, Choi JW, Kim YS: The presence of a micropapillary component predicts aggressive behaviour in early and advanced gastric adenocarcinomas. Pathology 2010, 42:560-563.10.3109/00313025.2010.50879020854075 Search in Google Scholar

38. Brown JM, Wasson MC, Marcato P: The missing Lnc: the potential of targeting triple-negative breast cancer and cancer stem cells by inhibiting long non-coding RNAs. Cells 2020, 9:763.10.3390/cells9030763714066232244924 Search in Google Scholar

39. Abadie J, Chocteau F, Loussouarn D, Nguyen F: Proposal for a Histological Staging System of Mammary Carcinomas in Dogs and Cats. Part 1: Canine Mammary Carcinomas. Frontiers in Veterinary Science 2019, 6:388.10.3389/fvets.2019.00388685402131788485 Search in Google Scholar

40. Liao GS, Hsu HM, Chu CH, Hong ZJ, Fu CY, Chou YC, Golshan M, Dai MS, Chen TW, De-Chian C, Tsai WC: Prognostic role of lymphovascular invasion and lymph node status among breast cancer subtypes. Journal of Medical Sciences 2018, 38:54.10.4103/jmedsci.jmedsci_105_17 Search in Google Scholar

41. Shi Y, Su WJ, Dai GZ: Development of a risk-stratification scoring system for predicting lymphovascular invasion in breast cancer. BMC cancer 2020, 20:94.10.1186/s12885-020-6578-0699885132013960 Search in Google Scholar

42. Ragage F, Debled M, MacGrogan G, Brouste V, Desrousseaux M, Soubeyran I, Tunon de Lara C, Mauriac L, de Mascarel I: Is it useful to detect lymphovascular invasion in lymph node-positive patients with primary operable breast cancer?. Cancer 2010, 116:3093-3101.10.1002/cncr.2513720564641 Search in Google Scholar

43. El Abbass KA, Abdellateif MS, Gawish AM, Zekri AR, Malash I, Bahnassy AA: The role of breast cancer stem cells and some related molecular biomarkers in metastatic and nonmetastatic breast cancer. Clinical breast cancer 2020, 20:e373-84.10.1016/j.clbc.2019.11.00832299754 Search in Google Scholar

44. Liu Y, Yang M, Luo J, Zhou H: Radiotherapy targeting cancer stem cells “awakens” them to induce tumour relapse and metastasis in oral cancer. International journal of oral science 2020, 12:1-12.10.1038/s41368-020-00087-0731153132576817 Search in Google Scholar

45. Szczubiał M, Łopuszynski W: Prognostic value of regional lymph node status in canine mammary carcinomas. Veterinary and comparative oncology 2011, 9: 296-303.10.1111/j.1476-5829.2011.00268.x22077411 Search in Google Scholar

46. Wei W, Hu H, Tan H, Chow LW, Yip AY, Loo WT: Relationship of CD44+ CD24-/low breast cancer stem cells and axillary lymph node metastasis. In Journal of translational medicine 2012, 10:1-6.10.1186/1479-5876-10-S1-S6344585823046710 Search in Google Scholar

47. Jones BC, Kelley LC, Loskutov YV, Marinak KM, Kozyreva VK, Smolkin MB, Pugacheva EN: Dual targeting of mesenchymal and amoeboid motility hinders metastatic behavior. Molecular Cancer Research 2017, 15:670-682.10.1158/1541-7786.MCR-16-0411545770528235899 Search in Google Scholar

48. Kariri YA, Aleskandarany MA, Joseph C, Kurozumi S, Mohammed OJ, Toss MS, Green AR, Rakha EA: Molecular Complexity of Lymphovascular Invasion: The Role of Cell Migration in Breast Cancer as a Prototype. Pathobiology 2020, 87:218-231.10.1159/00050833732645698 Search in Google Scholar

49. Cao R, Yuan L, Ma B, Wang G, Qiu W, Tian Y: An EMT-related gene signature for the prognosis of human bladder cancer. Journal of cellular and molecular medicine 2020, 24:605-617.10.1111/jcmm.14767693337231657881 Search in Google Scholar

50. Parvani JG, Schiemann WP: Sox4, EMT programs, and the metastatic progression of breast cancers: mastering the masters of EMT. Breast Cancer Research 2013, 15:1-3.10.1186/bcr3466397907623981787 Search in Google Scholar

51. Garg M: Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis. Expert Reviews in Molecular Medicine 2017, 19:1-13.10.1017/erm.2017.628322181 Search in Google Scholar

52. Luo A, Xu Y, Li S, Bao J, Lü J, Ding N, Zhao Q, Fu Y, Liu F, Cho WC, Wei X: Cancer stem cell property and gene signature in bone-metastatic Breast Cancer cells. International journal of biological sciences 2020, 16:2580-2594.10.7150/ijbs.45693741542232792858 Search in Google Scholar

53. Velasco-Velázquez MA, Popov VM, Lisanti MP, Pestell RG: The role of breast cancer stem cells in metastasis and therapeutic implications. The American journal of pathology 2011, 179:2-11.10.1016/j.ajpath.2011.03.005312386421640330 Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo